EUVIMEDEUVIMED entdecken
Crossref

Efficacy of octreotide in preventing lymphedema after radical, modified radical, and partial mastectomy with axillary lymphadenectomy

Sanjana Challa, Lacey Foster, Athena Ye, Sophia Ahn, Dorien I Schonebaum, Charlotte Thomas, Alynah Adams, Samuel J Lin

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026

DOI: 10.1016/j.bjps.2026.08.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026. Verfasst von Sanjana Challa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Octreotide, Lymph Node Excision, Lymphedema, Breast Neoplasms. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Postoperative octreotide is known to reduce lymphorrhea after axillary node dissection in breast cancer and other gynecological malignancies with varying efficacy. However, the effect of octreotide on the development of lymphedema after axillary node dissection has not been explored. We sought to evaluate the role of octreotide in preventing lymphedema in patients who underwent axillary lymphadenectomy. METHODS: This retrospective review of the TriNetX Analytics Network queried the Global Collaborative Network with over 170 million patients to identify patients undergoing complete axillary lymphadenectomy or radical, modified radical, or partial mastectomy with axillary node dissection. Then, the patients who received octreotide after surgery were identified. Patients with a history of octreotide use prior to surgery or hereditary lymphedema were excluded. Patients were identified using diagnosis and procedure codes. Occurrence of postoperative lymphedema was compared between 1:1 propensity score matched cohorts. Patients were matched for age, body mass index (BMI), gender, race, radiation therapy, and smoking among others. Risk ratios, t-tests, and Z-tests were used to compare outcomes. RESULTS: A total of 222 patients who underwent axillary lymphadenectomy and received octreotide postoperatively were matched to 222 patients who did not receive octreotide from an original pool of 69,955 patients. Prior to matching, the standardized mean difference between the two groups was greater than 0.1 for age, BMI, and several race categories. After matching, all standardized mean differences were less than 0.1. Patients who received octreotide were at significantly lesser risk of developing lymphedema (p 0.05) or hypothyroidism (p>0.05). CONCLUSIONS: Patients who underwent axillary lymphadenectomy and received octreotide postoperatively were associated with significantly less risk of developing lymphedema and undergoing surgical lymphedema correction without increased risk of hypothyroidism or bradycardia. This study establishes the potential role of octreotide for lymphedema prevention in patients undergoing axillary lymphadenectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OctreotideLymph Node ExcisionLymphedemaBreast NeoplasmsPostoperative ComplicationsMastectomyHumansFemaleRetrospective StudiesMiddle AgedAxillaMastectomy, SegmentalMastectomy, Modified RadicalAgedAdult

Stichwörter der Autor:innen

Axillary lymphadenectomyLymphedema preventionModified radical mastectomyOctreotidePostmastectomy lymphedemaRadical mastectomy

Substanzen

Octreotide

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Medical College of Wisconsin, Milwaukee, WI, USA.
  • Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: sjlin@bidmc.harvard.edu.

Zitieren

APA

Challa, S., Foster, L., Ye, A., Ahn, S., Schonebaum, D. I., Thomas, C., Adams, A., & Lin, S. J. (2026). Efficacy of octreotide in preventing lymphedema after radical, modified radical, and partial mastectomy with axillary lymphadenectomy. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2026.08.037

Vancouver

Challa S, Foster L, Ye A, Ahn S, Schonebaum DI, Thomas C, et al. Efficacy of octreotide in preventing lymphedema after radical, modified radical, and partial mastectomy with axillary lymphadenectomy. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026. doi:10.1016/j.bjps.2026.08.037

BibTeX
@article{Challa2026,
  author = {Challa, Sanjana and Foster, Lacey and Ye, Athena and Ahn, Sophia and Schonebaum, Dorien I and Thomas, Charlotte and Adams, Alynah and Lin, Samuel J},
  title = {Efficacy of octreotide in preventing lymphedema after radical, modified radical, and partial mastectomy with axillary lymphadenectomy},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2026},
  doi = {10.1016/j.bjps.2026.08.037}
}
Kostenlos starten →